Searched for
MERIL LIFE SCIENCES
PRISM-PCI Conclave 2026 in Vapi highlights India’s evolving approach to heart careThe PRISM-PCI Conclave 2026 highlighted India's significant advancements in cardiac care, showcasing its evolution from a consumer to a con...- ADIA signs a definitive agreement to invest $200 million in medical devices firm MerilAbu Dhabi Investment Authority (ADIA) is set to invest $200 million for a 3% stake in medical device maker Meril, valuing the company at $6...
- Abu Dhabi Investment Authority to buy 3% stake in Micro Life Sciences for $200 mnAbu Dhabi Investment Authority (ADIA) is set to acquire a 3% stake in the Indian medical device company, Micro Life Sciences Pvt Ltd (Meril...
- Warburg-backed Micro Life eyes $150 mn in pre-IPO round; eyes $5 bn valuationMicro Life Sciences, India's largest medical devices group, is seeking to raise $150 million by selling a small stake, aiming for a $5 bill...
- Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...
- Govt mulls over new category for advanced coronary stents, price ceiling increase to attract manufacturersThe government is considering creating a separate category for advanced coronary stents and raising the price ceiling to attract stent make...
- Warburg buys majority stake in ophthalmic device company AppasamyWarburg Pincus buys majority stake in Chennai's Appasamy Associates, a top Indian ophthalmic equipment and IOLs manufacturer. Appasamy CEO ...
- Warburg Pincus acquires Chennai's Appasamy AssociatesPSN Appasamy's Appasamy Associates, a key player in Indian ophthalmic market, focuses on affordable equipment and cataract surgeries. Warbu...
- Warburg Pincus to invest $ 210 million in medical devices firm MerilThe US private equity firm will be acquiring the shares through Warburg Pincus, through its Dutch affiliate South Elm Investments B.V., and...
- Meril Life Sciences launches indigenously developed bioresorbable scaffoldThis novel therapy option, which can meaningfully treat an identified subset of the patient population, will be launched in a phased, seque...
- Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuationEstablished in 1998, SMT develops and manufactures cardiac products that are sold in 75 countries. Its portfolio includes coronary stents (...
- Drug price regulator exempts Meril Life Sciences from price controls for a stent developed 3 years agoThis means that the firm has provided adequate justification to the government for launching its product at “any price" it wants. Meril Lif...
- NPPA defers decision on Meril’s stent pricing pleaMeril Life’s first locally made biodegradable cardiac scaffold, a naturally dissolving stent, is known as MeRes100. The stent was approved ...
- Patients' group opposes stent categorisationIn April 2015 and January 2018, expert committees examining the request for separate categories for 'innovative' stents had decided that th...
- Domestic stent makers gain on the back of price capsThis year, domestic stent firms are aiming for 60 per cent of the market estimated to be Rs 1,200 crore now due to a drop in the average pr...
- After dissolvable stent 'Absorb', Abbott moves to withdraw 'Xience Alpine'Abbott publicly announced intentions to stop global sales of dissolvable scaffold ‘Absorb’, which has been mired in controversy for risks r...
- First India-made dissolvable stent gets ministry nodUnlike drug-eluting stents that are made of metal and stay in the arteries forever, Meril’s 100 micron-thick BVS ‘MeRes100’ is made of mate...
- Pharma companies want you to pay more for 'risky' bioresorbable stentsBioresorbable scaffolds showed that the device might perform as well as a metallic stent clinically , but it also meant an “increased risk“...
- NPPA asks stent makers to furnish pricing data within a weekThe drug pricing watchdog stated that few companies still have not submitted the information and that some of them have not submitted the d...
- Surat captures 30% share of cardiac stents market in India, becomes largest manufacturerSurat, famed for its Rs 90,000 crore diamond industry, has emerged as the biggest manufacturer of cardiac stents in India.
Load More
